Healthcare / Medical Care FacilitiesSES
$0.03
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $2.8M · quality 61.3/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
35/100
D
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$16M
P/E
N/A
•EV/EBITDA
8.8x
↓ROE
3.2%
↑Gross Margin
78.1%
↑Debt/Equity
0.72
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
-3.8%
FCF CAGR
+9.6%
FCF margin
9.5%
FCF / Net income
12.47x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $29.3M · net income $223000.0 · FCF $2.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $29.3M | $29.3M | $27.6M | $25.4M | $32.9M |
| Net Income | $223000.00 | $223000.00 | $557000.00 | $-2.9M | $722694.00 |
| EBITDA | $2.2M | $2.2M | $3.0M | $-148146.00 | $4.0M |
| EPS | — | — | 0.00 | -0.01 | 0.00 |
| Gross Margin | 78.1% | 78.1% | 79.6% | 79.6% | 82.9% |
| Operating Margin | -0.5% | -0.5% | 1.4% | -5.0% | 7.3% |
| Net Margin | 0.8% | 0.8% | 2.0% | -11.3% | 2.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.72 | 0.72 | 0.87 | 2.42 | 1.52 |
| Current Ratio | 1.03 | 1.03 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $2.8M | $2.8M | $4.0M | $442137.00 | $2.1M |
| Returns | |||||
| ROE | 3.2% | 3.2% | 8.7% | -76.7% | 13.9% |
| Valuation | |||||
| P/E | — | — | 25.00 | — | 30.59 |
| EV/EBITDA | 8.80 | 8.80 | 5.34 | — | 6.62 |
| P/B | 2.37 | 2.37 | 2.09 | 2.36 | 4.37 |
| Growth & Yield | |||||
| Revenue Growth | 5.9% | 5.9% | 9.0% | -22.9% | — |
| EPS Growth | — | — | 112.3% | -482.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+23.8%
Start / end P/E
n/dx → n/dx
EPS bridge
0.00 → n/d
Residual
+23.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.